deltatrials
Completed OBSERVATIONAL NCT00111878

Study to Evaluate MEDI-534 in Healthy Adults

Dose-Escalating Study to Evaluate MEDI-534 in Healthy Adults

Sponsor: MedImmune LLC

Conditions Parainfluenza Infections Respiratory Syncytial Virus Infections
Interventions MEDI-534
Updated 6 times since 2017 Last updated: Jul 2, 2007 Started: Apr 30, 2005 Completion: Dec 31, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00111878, this observational or N/A phase trial focuses on Parainfluenza Infections and Respiratory Syncytial Virus Infections and remains completed. Sponsored by MedImmune LLC, it has been updated 6 times since 2005, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: PHASE1 → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Completed PHASE1

    First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • MedImmune LLC
Data source: MedImmune LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations